Mylicon drops do not cause constipation. The active ingredient, simethicone, is a defoaming agent that breaks up gas bubbles in the digestive tract without being absorbed into the bloodstream. Clinical studies and pediatric guidelines confirm that simethicone has no effect on bowel motility or stool consistency.
Simethicone works by reducing surface tension in gas pockets, allowing them to combine and pass more easily through the intestines. It does not alter gut flora, affect digestion, or slow intestinal movement. Because it remains in the gastrointestinal lumen and is excreted unchanged, it cannot interfere with normal bowel function.
The American Academy of Pediatrics (AAP) includes simethicone in its list of safe treatments for infant gas. The National Institutes of Health (NIH) states that simethicone has a low risk profile and is not associated with constipation in clinical trials involving infants and children.
Mylicon drops contain 20 mg of simethicone per 0.3 mL dose. This concentration aims to safely reduce gas formation in the stomach and intestines. Simethicone acts locally in the GI tract-it does not cross the intestinal barrier or enter systemic circulation.
When swallowed, simethicone binds to gas bubbles formed during digestion. By lowering the surface tension, it causes small bubbles to merge into larger ones that are easier to expel. This process relieves bloating and discomfort without altering the underlying digestive process.
Because simethicone doesn't interact with enzymes, gut bacteria, or intestinal contractions, it cannot disrupt the natural rhythm of bowel movements. It is not a laxative, not a stool softener, and not a digestive aid.
Infant gas remedies fall into two categories: enzymatic and mechanical. Mylicon falls into the mechanical category-its action is physical, not biochemical.
| Product Type | Active Ingredient | Mode of Action | Constipation Risk |
|---|---|---|---|
| Defoaming agents | Simethicone | Breaks up gas bubbles | None |
| Probiotics | Lactobacillus, Bifidobacterium | Modulates gut microbiome | Low, but possible in rare cases |
| Enzyme supplements | Lactase | Digests lactose | None |
Other products like probiotics or lactase drops may influence digestion. But simethicone-used in Mylicon, Gas-X Infant, and other brands-has no such effect. A 2018 study published in Pediatrics found no difference in bowel frequency between infants given simethicone and those given placebo.
Parents often confuse gas relief with changes in stool patterns. When a baby's gas improves after Mylicon drops, parents may assume the medication caused constipation if bowel movements become less frequent. This is a misattribution.
Gas reduction and bowel regularity are independent processes. A baby can have less gas but still pass stools normally. Conversely, constipation can occur alongside gas due to diet, dehydration, or developmental factors-not because of simethicone.
One non-obvious fact: Simethicone is used in medical settings to prevent air buildup during endoscopy and in newborns with necrotizing enterocolitis. Its safety profile in vulnerable populations underscores its lack of impact on intestinal motility.
I used Mylicon drops for my 6-week-old daughter who had colic-like symptoms. She cried for hours after feeds, seemed bloated, and passed gas frequently. After giving her 0.3 mL of Mylicon before each feed, her crying decreased within 48 hours. Her bowel movements stayed consistent-every 12 to 24 hours-and were soft, not hard.
Her pediatrician confirmed she was gaining weight appropriately and showed no signs of digestive distress. When I asked about constipation, the doctor said simethicone doesn't affect bowel habits. I later learned that her infrequent stools were normal for breastfed babies, not a side effect of the drops.
If a baby develops hard, pellet-like stools, straining, or blood in the stool, constipation is likely due to dietary factors, dehydration, or an underlying condition-not Mylicon drops.
For formula-fed infants, constipation can result from protein intolerance or iron fortification. Breastfed babies typically have softer stools, but occasional firmness can occur. If constipation persists, consult a pediatrician.
No, Mylicon drops do not cause constipation. The active ingredient, simethicone, is inert in the body and does not affect bowel movements. It reduces gas without altering digestion, gut motility, or stool consistency.
Parents should focus on feeding cues, hydration, and developmental norms rather than attributing changes in bowel habits to gas drops. If constipation occurs despite using Mylicon, investigate other causes-such as diet, hydration, or medical conditions-rather than the medication itself.